Latest Articles
Elite Women’s Health: Why Endometriosis Must Be a Priority - Medical Tourism Magazine
Elite Women’s Health: Why Endometriosis Must Be a Priority Medical Tourism Magazine
Published: Nov. 27, 2025, 6:12 p.m.
Why Switzerland Leads in High-Quality Endometriosis Treatment - Medical Tourism Magazine
Why Switzerland Leads in High-Quality Endometriosis Treatment Medical Tourism Magazine
Published: Nov. 27, 2025, 6:11 p.m.
Switzerland’s Most Trusted Endometriosis Specialist for Long-Term Relief - Medical Tourism Magazine
Switzerland’s Most Trusted Endometriosis Specialist for Long-Term Relief Medical Tourism Magazine
Published: Nov. 27, 2025, 6:09 p.m.
West Lothian woman fights for change after 'losing organs' to 'cruel' disease - Edinburgh Live
West Lothian woman fights for change after 'losing organs' to 'cruel' disease Edinburgh Live
Published: Nov. 27, 2025, 5:44 p.m.
Integrating inflammatory biomarkers and demographic variables with machine learning to predict endometriosis risk - Nature
Integrating inflammatory biomarkers and demographic variables with machine learning to predict endometriosis risk Nature
Published: Nov. 27, 2025, 5:43 p.m.
The Download: the fossil fuel elephant in the room, and better tests for endometriosis - MIT Technology Review
The Download: the fossil fuel elephant in the room, and better tests for endometriosis MIT Technology Review
Published: Nov. 27, 2025, 1:10 p.m.
Endometriosis Treatment Market at $1.55B, 7.7% CAGR - openPR.com
Endometriosis Treatment Market at $1.55B, 7.7% CAGR openPR.com
Published: Nov. 27, 2025, 10:19 a.m.
Endometriosis Market Analysis and Sales Forecast to 2034 - Leveraging Robust Pipeline Products, Tapping Into Emerging Markets, and Forming Strategic Partnerships - Yahoo Finance
Endometriosis Market Analysis and Sales Forecast to 2034 - Leveraging Robust Pipeline Products, Tapping Into Emerging Markets, and Forming Strategic Partnerships Yahoo Finance
Published: Nov. 27, 2025, 9:15 a.m.
'Cried for a week': the unseen emotional toll of 'excruciating' diagnosis - Western Advocate
'Cried for a week': the unseen emotional toll of 'excruciating' diagnosis Western Advocate
Published: Nov. 27, 2025, 8:39 a.m.
DESTINY-Endometrial01 Will Examine T-DXd Plus Rilvegostomig or Pembrolizumab in HER2+ pMMR Endometrial Cancer - OncLive
DESTINY-Endometrial01 Will Examine T-DXd Plus Rilvegostomig or Pembrolizumab in HER2+ pMMR Endometrial Cancer OncLive
Published: Nov. 26, 2025, 7:03 p.m.
Link copied to clipboard!